Cannabinoid receptors have been identified in the central nucleus of the amygdala, a key emotional hub in the brain.
Researchers report the protein FABP5, usually associated with diseases such as cancer and psoriasis, enhances cognitive function.
Amyloid beta has been implicated in blocking endocannabinoids in the hippocampus; impairing learning and memory long before Alzheimer's plaques form in the brain.
Researchers have discovered biological differences between males and females in the molecular regulation of synapses in the hippocampus.
Researchers report the 'love hormone', oxytocin, could enhance the pleasure of social interactions be stimulating the production of anandamide.
Researchers have discovered a lipid that may act as a 'switch' to increase or decrease the motivation to consume nicotine.
The findings could provide new insights into brain diseases such as Alzheimer's, schizophrenia and depression.
A new study finds THC reduces amyloid beta proteins in human neurons.